Gsk Share Discussion Threads

[solomon] 10/2/2017 09:47

andy, I think Trump said something in his sleep about pharma's being the next on the list after he has finished with the appeals court judges.

[andyadvfn1] 10/2/2017 09:45

After a nice rise this morning why the sudden reversal...pound related ?

[tim 3] 10/2/2017 09:35

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1720p (from 1800p).

Story provided by StockMarketWire.com

[ny boy] 10/2/2017 08:37

Usually get that when approaching a market top, buyer exhaustion philanderer.

GSK will be a defensive play when markets turn south. Happy holding and collecting a nice divi, I think 6%+!

[essentialinvestor] 09/2/2017 10:22

The bond proxy stocks had a nice few days with yields suggesting
inflationary expectations are muted, big move on the UK 10-Year over
the last week. May also explain why real estate is getting some support.

[philanderer] 09/2/2017 10:17

Market seems stuck this morning . Just GSK , AZN and MKS moving for me , everything else dead as a dodo

[philanderer] 09/2/2017 09:43

FWIW reiterations today...

9th feb Deutsche hold tp 1800p
9th feb JP Morgan neutral tp 1600p
9th feb Liberum buy tp 1900p

[ny boy] 09/2/2017 09:08

Broker upgrade to 1900p. Solid play 5% divi at present ..I've been buying more this morning for the pension fund.

[essentialinvestor] 09/2/2017 08:52

Very welcome.

[ny boy] 09/2/2017 08:41

Onwards to 1700p

[philanderer] 08/2/2017 20:34

GSK needs no medicine despite talk of poor performance

[essentialinvestor] 08/2/2017 17:19

Very nice recovery, thought we may have got a double dip,
the considered reaction was more positive.

[ny boy] 08/2/2017 16:41

Nice dip buying at support, onwards & upwards

[philanderer] 08/2/2017 16:25

GlaxoSmithKline chief Witty defends his strategy as he prepares to step down

[essentialinvestor] 08/2/2017 14:21

FCF looks strong if you strip out the long list of charges, has there
been one year in the past 10 where GSK has not paid a hefty legal charge!.

ViiV is the absolute standout.

[alphorn] 08/2/2017 14:02

Returning to my earlier post 'Intangibles' sitting on the balance Sheet at £18.8bn are now the single largest line item on the balance sheet. Made up mainly of brands, patents etc. Growing like topsy and needs watching IMO. It has the potential IMO to be an accounting convention time bomb in the future.

[fangorn2] 08/2/2017 13:28

I guess it was the outlook and generic impact on Advair that Market doesnt view favourably..

"Core earnings guidance for 2017:

5-7% at CER in the event of no generic competition to Advair in the US,

or

"flat to a slight decline" if a substitutable generic competitor to Advair is launched in the US mid-year, which would be expected to lead to full year 2017 US Advair sales of around £1bn at CER."


Still holding.A solid blue chip to tuck away imo.


Upside

"With regulatory decisions on four major potential products expected this year, Shingrix, Closed Triple, Benlysta SC and sirukumab, he remained confident in the mid-term financial outlook previously set out.

[essentialinvestor] 08/2/2017 12:58

Thank goodness they have ViiV!.

[tradermichael] 08/2/2017 12:57

Well done - and the price will quickly reflect another outstanding set of figures. The pipeline is also looking good for the future ....... ;0)

[hernando2] 08/2/2017 12:48

Well i was by good luck sitting at the computer when that dip happened an bought accordingly....very nice

[tradermichael] 08/2/2017 12:46

A ridiculous fall ahead of the release. What did the "market" think - did it believe that GSK's figures would collapse in the last 3 months of their reporting year? ....... ;0)

[andyadvfn1] 08/2/2017 12:28

Of course would have liked to see share price rise but as it did not, took the opportunity to increase my holding by 10%.Roll on the divi.

[essentialinvestor] 08/2/2017 12:26

Doing a Bobby Vee atm, another leg down in US trading?.

[robrah] 08/2/2017 12:25

Well topped up . Divi is good will wait for recovery